Chicago-based independent futures brokerage and clearing firm R.J. O’Brien & Associates (RJO) has hired industry veteran Daniel Staniford as Executive Director, responsible for the firm’s institutional business development in New York and London.
Saturday, 3 December 2016
Last updated 10 hours ago
Dec 3 2008 | 12:13pm ET
(Source: VC Circle) -- Last week India dominated the news for all the wrong reasons. But despite the negative headlines coming out of Mumbai, India is still a hot place to invest right now, and one U.S. firm is betting the good times will continue.
Chicago-based investment firm McNally Capital is advising a family office on setting up a $150 million healthcare focused private equity fund in India. VC Circle's Shrija Agrawal spoke to John P. Rompon, a managing partner at McNally Capital, on their plans for the region.
VC Circle: How is McNally's strategy in India evolving?
Rompon: As a buyout fund, we will take control positions in companies that can leverage India either as a "sell to" or "deliver from" destination. We could subsequently look at those firms making acquisitions abroad. We believe that there is a trend of Indian companies making acquisitions in the U.S. We see an opportunity where our portfolio companies can be acquired by Indian companies. Our experience in India would be helpful.
Secondly, as for our managed account business, our family office clients like to make investments in India, either in the funds which have an India focus, fund of funds with an India focus or directly in Indian companies.
VC Circle: What do you think about the India story? How do you see that unfolding?
Rompon: I am very bullish on India and have been for several years. My bullishness does not come from an interest in labor arbitrage, but rather from a first hand observation of the talent and skill level that's available from the workforce. India has an advantage over several other developing countries.
VC Circle: Private equity is still at a nascent stage in India. We don't see many controlled transactions. Do you think that India will transition to a mature buyout market?
Rompon: I think the balance of trade between India and the rest of the world will revert to positive from its current negative, and I believe that liberalization of foreign direct investment will encourage control investments. One challenge is that within India, the best companies are family controlled and these families are typically reluctant to give up control. So the first stage in the process may be that domestic or foreign investors are allowed to take economic control of Indian companies but not take governance control. It goes on to say that even if the investors own more than 50% of the shares, they won't necessarily be able to control the board. The second phase would be permitting domestic or foreign investors to take both economic and governance control.
VC Circle: Are there any particular deals that you are working on right now in India?
Rompon: Yes, the areas that interest us are principally in healthcare and business services. We are currently working with one of our investors who wants to set up a private equity fund focused on healthcare opportunities in India.
VC Circle: Which one is that?
Rompon: I can't identify the investor for you. I would just describe this as an Indian family that's been in the U.S. for the past 20 years.
VC Circle: Do you think its easy to raise funds right now?
Rompon: No, it's not easy to raise funds right now, but it's a great time to invest.
VC Circle: Any value picks that you are seeing in India right now?
Rompon: The best time to invest historically has been during a recessionary period and negative GDP growth. In the U.S., we have negative GDP growth now, which is an outstanding time to invest. Within India there is no negative GDP growth, and it is expected to grow at 6 to 7%. Since it's a slow and a tedious growth rate (for a growth market like India), it is an attractive opportunity to invest in private equity in India.
I don't pretend to understand the public markets in India or elsewhere, but within private equity I do think this is an attractive time to invest and the sectors that are particularly attractive have to do with staple sectors such as power, food, infrastructure and other basic commodities or companies that serve those sectors.
I also believe that, over the last 20 years, private equity has consistently delivered the highest risk adjustability returns than any other asset class. Secondly, more and more institutional investors are adopting an endowment style of private equity that involves investing in an asset class year over year rather than trying to time the market. I believe that all investors—both institutional and individual—have come to understand the nature of private equity investing with regard to the cash flow and other elements of it, and their expectations have matured.
VC Circle: Which sub-sector within healthcare are you most upbeat about?
Rompon: Historically, spending on healthcare increases faster than the rate at which GDP grows and this is one reason why we have been taking a hard look at the healthcare sector in India. We and our investors feel that the best opportunities that are available are in service delivery and, in particular, ambulatory care. We believe that those investments offer the greatest returns and the greatest opportunity to positively impact healthcare within India.
VC Circle: Are you be looking at any PIPE transactions?
Rompon: Absolutely not.
VC Circle: Are you looking at distressed investing now?
Rompon: We aren't targeting distressed investing, but we are targeting companies which have reached a point where they can't grow without some assistance.
(VC Circle is an official content provider for FINalternatives)